Key facts
- It has raised $13.0M; the latest was Seed Round ($13.0M) in Feb 2025.
- Notable investors include Roivant Sciences.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zest Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Zest Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zest Health
Developer of a healthcare platform designed to leverage technology to provide personalized, supportive care for skin health and dermatological needs. The company's platform offers a wide range of features including rapid access to a board-certified dermatologist, a personalized treatment plan, prescription refills online, unlimited messaging with experts, regular progress monitoring, enabling patients with psoriasis, eczema, and other chronic skin conditions with a treatment plan tailored as per the unique needs and personal goals.
- Sector
- Healthcare
- HQ
- Menlo Park, CA, United States
- Founded
- 2022
- Employees
- 19
- Website
- zesthealth.com/
- Ownership
- Privately Held (backing)
Zest Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zest Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zest Health in its N-PORT filings yet. We sweep new filings monthly.